These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7610837)
21. Lymphoepithelioma of the larynx. Andryk J; Freije JE; Schultz CJ; Campbell BH; Komorowski RA Am J Otolaryngol; 1996; 17(1):61-3. PubMed ID: 8801819 [No Abstract] [Full Text] [Related]
22. Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines. Erlich E; McCall AR; Potkul RK; Walter S; Vaughan A Gynecol Oncol; 1996 Feb; 60(2):251-4. PubMed ID: 8631547 [TBL] [Abstract][Full Text] [Related]
23. Apoptotic mechanism of paclitaxel-induced cell death in human head and neck tumor cell lines. Hsiao JR; Leu SF; Huang BM J Oral Pathol Med; 2009 Feb; 38(2):188-97. PubMed ID: 19200178 [TBL] [Abstract][Full Text] [Related]
24. Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines. Raitanen M; Rantanen V; Kulmala J; Pulkkinen J; Klemi P; Grénman S; Grénman R Int J Cancer; 2002 Feb; 97(6):853-7. PubMed ID: 11857367 [TBL] [Abstract][Full Text] [Related]
25. The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes. Schmidt M; Polednik C; Gruensfelder P; Roller J; Hagen R Oncol Rep; 2009 May; 21(5):1297-305. PubMed ID: 19360307 [TBL] [Abstract][Full Text] [Related]
26. Subadditive interaction of radiation and Taxol in vitro. Ingram ML; Redpath JL Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1139-44. PubMed ID: 9169824 [TBL] [Abstract][Full Text] [Related]
28. Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells. Wang C; Guo L; Wang S; Wang J; Li Y; Dou Y; Wang R; Shi H; Ke Y; Liu H Int J Mol Med; 2017 Mar; 39(3):645-653. PubMed ID: 28204832 [TBL] [Abstract][Full Text] [Related]
29. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma. Steinberg L; Hassan M; Olmsted L; Sharan V; Stepnick D; Hoppel C; Mugharbil A; Subramanyan S; McGloin B; Mackay W; Strauss M Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-51-S19-56. PubMed ID: 9427267 [TBL] [Abstract][Full Text] [Related]
30. Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki ). Pradier O; Rave-Fränk M; Lehmann J; Lücke E; Boghun O; Hess CF; Schmidberger H Int J Cancer; 2001 Mar; 91(6):840-5. PubMed ID: 11275989 [TBL] [Abstract][Full Text] [Related]
31. Radiotherapeutic management of laryngeal carcinoma. Hristov B; Bajaj GK Otolaryngol Clin North Am; 2008 Aug; 41(4):715-40, vi. PubMed ID: 18570955 [TBL] [Abstract][Full Text] [Related]
32. Cell line and schedule-dependent cytotoxicity of paclitaxel (Taxol): role of the solvent Cremophor EL/ethanol. Cordes N; Plasswilm L Anticancer Res; 1998; 18(3A):1851-7. PubMed ID: 9673415 [TBL] [Abstract][Full Text] [Related]
33. Primary aspergillosis of the larynx and squamous cell carcinoma. Beust L; Godey B; Le Gall F; Grollier R; Le Clech G Ann Otol Rhinol Laryngol; 1998 Oct; 107(10 Pt 1):851-4. PubMed ID: 9794614 [TBL] [Abstract][Full Text] [Related]
34. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model. Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108 [TBL] [Abstract][Full Text] [Related]
35. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial. Cmelak AJ; Murphy BA; Burkey B; Douglas S; Shyr Y; Netterville J Head Neck; 2007 Apr; 29(4):315-24. PubMed ID: 17252600 [TBL] [Abstract][Full Text] [Related]
36. [Radiosensitization of paclitaxel combined with radiation on nasopharygneal carcinoma cells (CNE-I) in vitro]. Yuan ZY; Yang WZ; Jin J; Gao L; Liu XF; Xu GZ Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):649-52. PubMed ID: 18246791 [TBL] [Abstract][Full Text] [Related]
37. Induction of cisplatinum sensitivity without alteration in radiation sensitivity by fractionated radiation treatment of a human laryngeal squamous cell carcinoma cell line. Redpath JL; Hyden EC; Sun C Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):681-5. PubMed ID: 7790254 [TBL] [Abstract][Full Text] [Related]
38. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Dietz A; Rudat V; Dreyhaupt J; Pritsch M; Hoppe F; Hagen R; Pfreundner L; Schröder U; Eckel H; Hess M; Schröder M; Schneider P; Jens B; Zenner HP; Werner JA; Engenhardt-Cabillic R; Vanselow B; Plinkert P; Niewald M; Kuhnt T; Budach W; Flentje M Eur Arch Otorhinolaryngol; 2009 Aug; 266(8):1291-300. PubMed ID: 18972123 [TBL] [Abstract][Full Text] [Related]
39. Paclitaxel and irradiation induce apoptosis in squamous cell carcinoma cell lines in an additive way. Pulkkinen JO; Pekkola-Heino K; Grénman R Anticancer Res; 1996; 16(5A):2923-9. PubMed ID: 8917408 [TBL] [Abstract][Full Text] [Related]
40. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells. Gorodetsky R; Levdansky L; Ringel I; Vexler A Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]